Cocaine and Skin: Levamisole Contamination, Vasculitis, and What to Watch For

Most people who use cocaine are not using pure cocaine. The DEA has estimated that 70–80% of the U.S. cocaine supply contains levamisole — a veterinary anthelmintic (a deworming medication used in livestock) that resembles cocaine in appearance, enhances the perceived intensity of the high, and is difficult to remove from the supply chain once added. For most people, levamisole exposure produces no visible reaction. For 2–5% of people exposed to levamisole-adulterated cocaine, it triggers an autoimmune reaction that presents on the skin and, in more severe cases, in the blood and other organ systems.

Understanding this matters for two reasons: the skin presentations are alarming, often poorly recognized by clinicians who aren't looking for the levamisole connection, and the treatment is straightforward — stopping cocaine removes the trigger, and the natural history of the reaction is benign if the trigger is removed early.

TL;DR: Levamisole, found in the majority of U.S. cocaine, can trigger ANCA-associated vasculitis (inflammation of the blood vessels) in susceptible people — presenting as distinctive purple, net-like (retiform purpura) skin lesions, most commonly on the ears, nose, cheeks, and extremities. The condition is serious but largely reversible: DermNet and published case series document resolution within 2–3 weeks after stopping cocaine and removing levamisole exposure. Most presentations warrant same-day urgent care (not emergency care) for evaluation, baseline bloodwork, and diagnosis. There are specific signs that upgrade the urgency to an emergency room visit or 911 — this article enumerates them directly so you can make the call.

---

What is levamisole and why is it in cocaine?

Levamisole (chemical name: (S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole) was once used as a human anthelmintic — a drug to treat parasitic worm infections — but was withdrawn from the U.S. market for human use after it was linked to agranulocytosis (a severe drop in white blood cells) in some patients. It remains in use as a veterinary medication.

Levamisole enters the cocaine supply at the processing stage, likely because:

• It is inexpensive and resembles cocaine hydrochloride visually, making it effective as a bulking agent
• It has mild stimulant properties that enhance the subjective effects of cocaine, making adulterated product subjectively similar to higher-purity cocaine
• It is difficult to detect without laboratory analysis

The DEA's 2009 and subsequent annual drug threat assessments documented the rapid spread of levamisole in the U.S. cocaine supply — rising from trace amounts to majority prevalence within a few years of widespread introduction.

---

What levamisole does in the body

In susceptible individuals, levamisole triggers an ANCA-associated vasculitis — an autoimmune response in which the immune system produces antineutrophil cytoplasmic antibodies (ANCA) that attack the walls of small blood vessels. The same antibody response was responsible for the agranulocytosis seen in levamisole's human pharmaceutical history.

This produces two clinically important effects:

Cutaneous vasculitis (skin vessel inflammation): The visible skin reaction — the purple, net-like lesions (retiform purpura) — results from blood vessel inflammation and small vessel occlusion in the skin. The lesions are most common on the ears, nose, cheeks, and extremities (hands, feet, lower legs). They can progress from faint discoloration to frank purpura and, in severe cases, to skin necrosis (tissue death).

Agranulocytosis (white blood cell depletion): Levamisole suppresses the bone marrow's production of granulocytes — the white blood cells responsible for fighting bacterial infections. Severe agranulocytosis leaves a person without the immune defenses needed to fight ordinary infections, and can progress to neutropenic sepsis (a life-threatening infection with no immune response).

Both effects resolve when levamisole exposure ends — meaning when cocaine use stops.

---

What the skin reaction looks like

The levamisole-associated skin reaction has a recognizable pattern. Key features:

Location: Ears are the most characteristic and frequently cited location — purpuric lesions on the ears that are disproportionately prominent compared to other skin involvement. Also common: nose, cheeks, and extremities (hands, feet, lower legs, and ankles).

Appearance: The lesions begin as faint purple or dark-red discolorations, often with a net-like or lacy pattern (retiform purpura). They may be flat or slightly raised. With progression, they can darken and develop central necrotic areas (appearing black or brown in the center).

Onset: Typically develops after repeated exposure rather than first use — the autoimmune mechanism requires a sensitization period.

Associated symptoms: Skin lesions may occur in isolation or alongside joint pain, fatigue, and fever. The absence of systemic symptoms does not rule out agranulocytosis, which can be present without obvious symptoms until an infection develops.

---

When to seek care — and what level of care

Most levamisole skin reactions need same-day evaluation, not emergency care. The natural history is benign if the trigger is removed. But there are specific signs that change the calculus — and you need to know them before you need them.

Same-day urgent care or primary care (same-day appointment)

Seek same-day evaluation when you notice:

• Purple, retiform (net-like), or purpuric skin lesions, particularly on the ears, nose, cheeks, or extremities
• Dark or discolored patches developing on skin, even if asymptomatic
• Joint pain accompanying skin findings
• Any skin change you suspect might be a reaction to cocaine use

What the same-day visit accomplishes: diagnostic evaluation (clinical + biopsy if indicated), a baseline complete blood count (CBC) to screen for agranulocytosis, an ANCA panel, and baseline urinalysis and creatinine to screen for renal vasculitis (which can occur in ANCA-associated conditions).

The most important intervention is also the most straightforward: stopping cocaine removes the levamisole exposure, removes the trigger, and allows the immune response to resolve. DermNet NZ documents resolution of levamisole-associated ANCA vasculitis within 2–3 weeks of stopping cocaine in most presentations that haven't progressed to necrosis.

Emergency room — go now

Upgrade to an emergency room visit (do not wait for an appointment) when any of the following are present:

• Skin necrosis: skin turning black, developing deep ulcers, or sloughing off. This indicates tissue death from vessel occlusion and requires urgent surgical and hematologic evaluation
• Fever of 38.5°C (101.3°F) or higher with the skin findings: this combination suggests possible neutropenic sepsis — a fever in the context of agranulocytosis is a medical emergency requiring immediate evaluation and possible IV antibiotics
• Severe sore throat or mouth sores alongside skin findings: these are signs of agranulocytosis; without white blood cells, the mucosal surfaces become infected
• Gross hematuria (blood in urine), pulmonary symptoms (cough, coughing up blood, shortness of breath), or neurological changes: these indicate multi-system vasculitis involvement requiring hospital-level evaluation
• "I feel very sick" alongside any skin finding: trust this signal. Vasculitis with systemic involvement can deteriorate rapidly.

Call 911

Call 911 immediately if:

• High fever, severe rigors (uncontrollable shaking), hypotension, or confusion alongside skin findings — this is possible neutropenic sepsis, which can become life-threatening within hours
• Respiratory distress (severe shortness of breath, can't complete a sentence)
• Sudden severe confusion, loss of consciousness

The framing that matters: This is not a cardiac article or a seizure article — this is not a situation where the default is "call 911." Most levamisole skin reactions are serious enough to warrant same-day evaluation, but they have a benign natural history if the trigger is removed and appropriate monitoring is in place. The emergency escalation is for specific presentations, not the general case. Knowing that distinction is the useful thing to carry away from this article.

---

Why clinicians may not recognize it

Levamisole-associated ANCA vasculitis is underdiagnosed because:

1. Clinicians don't ask about cocaine use — or patients don't disclose it, especially in environments where disclosure feels unsafe
2. The skin presentation can be mistaken for other conditions — vasculitis, immune complex disease, cryoglobulinemia, purpura fulminans — without the cocaine history, the levamisole connection is not on the differential
3. ANCA positivity in a young person without rheumatologic disease history is unexpected — without the cocaine context, a positive ANCA panel may prompt an extensive rheumatologic workup rather than a direct intervention

If you are seeking care for a skin reaction you suspect may be connected to cocaine use, telling the clinician about cocaine use — including levamisole contamination as a possible cause — will focus the evaluation. The most relevant tests: ANCA panel (particularly p-ANCA/MPO), CBC with differential, creatinine/UA. The most relevant intervention: cocaine cessation.

---

What improves when cocaine stops

The published case literature on levamisole-associated ANCA vasculitis is consistent: skin lesions resolve, ANCA levels typically normalize, and agranulocytosis reverses — when cocaine use stops and levamisole exposure ends.

The timeline in most reported cases: 2–3 weeks for skin lesion resolution in standard presentations; agranulocytosis reversal follows a similar timeline. Biopsy findings (leukocytoclastic vasculitis on skin biopsy) are the characteristic pathology.

If skin lesions do not improve within 3–4 weeks of cocaine cessation, follow up with the same-day care provider. Non-resolution warrants rheumatologic evaluation to rule out an underlying ANCA-associated vasculitis that exists independently of levamisole exposure.

---

Connection to other cocaine-related health effects

Levamisole also contributes to liver inflammation in some exposed individuals — the immune-mediated pathway (ANCA) can affect hepatic vasculature in addition to cutaneous and renal vessels. If liver symptoms (jaundice, dark urine, right upper quadrant pain) accompany skin findings, this warrants an expanded liver function evaluation alongside the skin workup.

The cocaine-and-skin and cocaine-and-liver presentations can overlap in people with significant levamisole exposure — particularly in people who were also using alcohol with cocaine (where cocaethylene adds a second hepatotoxic mechanism).

---

What to do now

If you have noticed skin changes you suspect may be connected to cocaine use:

1. Seek same-day evaluation — urgent care or primary care, same-day appointment. Bring this article if helpful for framing the levamisole conversation with your provider.
2. Go to an emergency room if you have fever, skin necrosis, systemic symptoms, or feel severely unwell.
3. Call 911 if you have severe fever with rigors, hypotension, confusion, or respiratory distress.
4. Stopping cocaine is the treatment — removing the levamisole exposure allows the immune response to resolve. This is not an article that ends with "in the meantime, here's how to manage it." The intervention is cessation.

For treatment support: findtreatment.gov or SAMHSA's National Helpline at 1-800-662-4357 (free, confidential, 24/7).

---